Purine Metabolism of Lymphocytes: Targets for Chemotherapy Drug Development
- 1 April 1994
- journal article
- review article
- Published by Elsevier in Hematology/Oncology Clinics of North America
- Vol. 8 (2), 357-381
- https://doi.org/10.1016/s0889-8588(18)30177-1
Abstract
No abstract availableThis publication has 99 references indexed in Scilit:
- Cardiac complications observed in elderly patients following 2′‐deoxycoformycin therapyAmerican Journal of Hematology, 1991
- Treatment of advanced chronic lymphocytic leukemia by fludarabineAnnals of Hematology, 1991
- Activity of Fludarabine Monophosphate in Patients With Advanced Mycosis Fungoides: A Southwest Oncology Group StudyJNCI Journal of the National Cancer Institute, 1990
- Lasting Remissions in Hairy-Cell Leukemia Induced by a Single Infusion of 2-ChlorodeoxyadenosineNew England Journal of Medicine, 1990
- Pentostatin in Hairy Cell Leukemia: Treatment by the Special Exception MechanismJNCI Journal of the National Cancer Institute, 1989
- Morphological Changes in Leukemic Lymphoblasts and Normal Lymphocytes Treated with Deoxyadenosine Plus DeoxycoformycinCancer Investigation, 1985
- The Pharmacology and Metabolism of the Thiopurine Drugs 6-Mercaptopurine and AzathioprineDrug Metabolism Reviews, 1985
- 2-Fluoro-ATP: A toxic metabolite of 9-β-D-arabinosyl-2-fluoroadenineBiochemical and Biophysical Research Communications, 1983
- Synthesis and biological activity of selected 2,6-disubstituted(2-deoxy-.alpha.- and -.beta.-D-erythro-pentofuranosyl)purinesJournal of Medicinal Chemistry, 1972
- Temporary Remissions in Acute Leukemia in Children Produced by Folic Acid Antagonist, 4-Aminopteroyl-Glutamic Acid (Aminopterin)New England Journal of Medicine, 1948